March 7, 2018 / 7:56 PM / 3 months ago

BRIEF-U.S. FDA Continues To Monitor Adverse Events Connected With Essure

March 7 (Reuters) - U.S. Food And Drug Administration:

* U.S. FDA SAYS AT CURRENT TIME, IS ACTIVELY EVALUATING A COLLECTION OF NEW MEDICAL DEVICE REPORTS SUBMITTED TO FDA ON ESSURE DEVICE

* U.S FDA SAYS OF THE NEARLY 12,000 REPORTS RECEIVED IN 2017 FOR ESSURE, THE MAJORITY WERE SENT TO FDA IN LAST QUARTER OF THE YEAR

* U.S. FDA SAYS CONTINUES TO BELIEVE THAT ESSURE MAY BE APPROPRIATE FOR SOME WOMEN BASED ON FDA’S CURRENT INFORMATION

* U.S. FDA SAYS ALSO RECOGNIZES THAT “SERIOUS PROBLEMS” HAVE BEEN ASSOCIATED WITH USE OF ESSURE

* U.S. FDA SAYS CONTINUING TO MONITOR ADVERSE EVENTS CONNECTED WITH ESSURE REPORTED TO FDA’S DATABASE, AS WELL AS OTHER DATA SOURCES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below